The Rector of Universitas Indonesia, Heri Hermansyah, stated that the\ncollaboration with Tsinghua University in developing an mRNA-based\ndengue fever vaccine is capable of providing a multiplier effect, such\nas industrial downstreaming and the strengthening of the National\nImmunisation Programme.<\/p>\n
During the launch of the mRNA-based dengue vaccine prototype in\nJakarta on Wednesday, Heri noted that the collaboration serves as a form\nof high-level academic diplomacy. He expressed hope that this\ncollaborative vaccine development could create a significant milestone\nin the national health system.<\/p>\n
\u201cWe are not just initiating student exchanges. We are actively\nworking together to create life-saving health technologies, with support\nfrom the Ministry of Health and the Indonesian Food and Drug Authority\n(BPOM),\u201d he said.<\/p>\n
According to Heri, the government has facilitated this cooperation\neffectively, ensuring that the phases from initial laboratory testing to\nclinical trials can proceed smoothly.<\/p>\n
He also hopes this collaboration will mark the beginning of vaccine\ninnovation, aligning with the vision of Minister of Health Budi Gunadi\nSadplin, who has called for the development of 11 vaccines so that all\nvaccines used in the National Immunisation Programme can be produced\ndomestically by Indonesia.<\/p>\n
On the same occasion, the Vice President of Tsinghua University, Wu\nHuaqiang, stated that this collaboration is a tangible fruit of\ncooperation between China and Indonesia.<\/p>\n
\u201cDengue fever has long plagued Southeast Asia. Traditional vaccine\nplatforms have certain limitations, whereas mRNA technology offers new\nopportunities to develop safer vaccines that can be adapted by local\nsystems,\u201d he said.<\/p>\n
With the support of the Beijing International Science and Technology\nCooperation Base, Wu Huaqiang noted that Tsinghua University and UI\npossess a strong foundation for joint research to address this\nissue.<\/p>\n
The collaboration, which was formalised on Wednesday, has three\nprimary objectives: increasing mRNA vaccine research capacity and\nexploring opportunities for other vaccine collaborations; developing\nbiotechnology talent through academic partnerships; and contributing to\na replicable model for a collective response to regional infectious\ndisease threats.<\/p>", "url": "https:\/\/jawawa.id\/newsitem\/ui-dengue-mrna-vaccine-development-with-tsinghua-yields-multiplier-effect-1783511773", "image": "" }, "sponsor": "Okusi Associates", "sponsor_url": "https:\/\/okusiassociates.com" }